Cognition Therapeutics, Inc. (CGTX)
Nasdaq: CGTX · Biological Products, (No Diagnostic Substances) · Purchase, NY · filing with the SEC since 2009
Who runs Cognition Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ricciardi Lisa
CEO & President. First filing Oct 2021, latest Apr 20, 2026, 5 filings in all.
Officers reporting now
3
of 17 people with a filing in the last fifteen months
Directors reporting now
14
32 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Doyle John Brendan | Chief Financial Officer | May 2023 | May 4, 2026 | none |
| Ricciardi Lisa | CEO & President | Oct 2021 | Apr 20, 2026 | none |
| Caggiano Anthony | Chief Medical Officer | Nov 2021 | Apr 20, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bios Advisors Gp, LLC | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Capital Management, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Equity Partners II, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Equity Partners, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Fund I Qp, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Fund I, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Fund II Qp, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Fund II, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Bios Memory Spv I, LP | director | Oct 2021 | Jun 22, 2026 | none |
| Fletcher Aaron G.L. | director | Oct 2021 | Jun 22, 2026 | none |
| Khattar Jack A. | director | Oct 2021 | Jun 22, 2026 | none |
| Monia Brett P | director | Oct 2021 | Jun 22, 2026 | none |
| Richstone Ellen B | director | Nov 2021 | Jun 22, 2026 | none |
| Wallace Peggy | director | Oct 2021 | Jun 22, 2026 | none |
Earlier names on the record17, newest filing first
Bios Equity Partners III, LP · director · last filing Jun 2025Bios Fund II Nt, LP · director · last filing Jun 2025Bios Fund III Nt, LP · director · last filing Jun 2025Bios Fund III Qp, LP · director · last filing Jun 2025Bios Fund III, LP · director · last filing Jun 2025Bios Memory Spv II, LP · director · last filing Jun 2025Bp Directors, LP · director · last filing Jun 2025Cavu Advisors, LLC · director · last filing Jun 2025Cavu Management, LP · director · last filing Jun 2025Kreis Leslie W. · director · last filing Jun 2025Bios Clinical Opportunity Fund, LP · director · last filing Nov 2023Bios Equity Cof, LP · director · last filing Nov 2023Golden Seeds Cognition Therapeutics LLC · 10% owner · last filing Sep 2022Einhorn Andrew J. · officer · last filing Aug 2022O'Brien James Michael · officer · last filing Mar 2022Breedlove Mark H. · director · last filing Oct 2021Ogden Cap Associates, LLC · 10% owner · last filing Oct 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.